Ge, Gaoxiang

Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor. [electronic resource] - Proceedings of the National Academy of Sciences of the United States of America Jun 2007 - 10010-5 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

0027-8424

10.1073/pnas.0704179104 doi


Amino Acid Sequence
Amino Acid Substitution
Angiogenesis Inhibitors--chemistry
Animals
Bone Morphogenetic Protein 1
Bone Morphogenetic Proteins--chemistry
Cell Proliferation--drug effects
Cells, Cultured
Chorioallantoic Membrane--drug effects
Dose-Response Relationship, Drug
Embryo, Mammalian--cytology
Endothelial Cells--drug effects
Endothelium, Vascular--cytology
Fibroblasts--cytology
Genes, Reporter
Growth Hormone--genetics
Homozygote
Humans
Luciferases--metabolism
Metalloendopeptidases--chemistry
Mice
Mitogen-Activated Protein Kinase 1--antagonists & inhibitors
Mitogen-Activated Protein Kinase 3--antagonists & inhibitors
Molecular Weight
Peptide Library
Phosphorylation--drug effects
Prolactin--metabolism
Protein Processing, Post-Translational
Recombinant Proteins--metabolism
Substrate Specificity
Umbilical Veins--cytology